Diagnosis and Treatment of Vestibular Disorders
Duke's balance disorders experts specialize in inner-ear disorders that affect balance, including:
- Migraine-associated vertigo
- Meniere’s disease
- Benign paroxysmal positional vertigo (BPPV)
- Vestibular neuritis and labyrinthitis
- Acoustic neuroma
- Perilymph fistula
- Intracranial hypertension
- Mal de débarquement
- Persistent perceptual-postural dizziness
Personalized Rehabilitation Program
We conduct a comprehensive consultation to determine if vestibular rehabilitation therapy will help your dizziness or unsteadiness. This includes an evaluation of your current abilities, such as finding out which positions or movements spark symptoms of dizziness or unsteadiness. Our vestibular rehabilitation therapists then design a personalized rehabilitation program to improve your symptoms, restore function, prevent falls, and enhance your quality of life. We use the initial evaluation of your abilities to track your progress over time. We also have physical therapists who are trained in cognitive behavioral therapy, which can be very helpful for specific types of dizziness.
Comprehensive Approach to Balance Problems
Expert Care Produces Excellent Outcomes
Our balance assessment and treatment team includes neurotologists who specialize in vestibular disorders (inner-ear balance system), balance problems, and all forms of dizziness; PhD- and AuD-level audiologists trained in vestibular assessment; and PhD-level physical therapists who work only with vestibular rehabilitation patients.
Research on Balance Programs
Our specialists focus their research on balance problems, including migraine-associated vertigo; Meniere’s disease; chronic, disabling disequilibrium; and viral inner-ear diseases. We are conducting several studies that are providing insights aimed at improving therapies for these often disabling conditions.
Clinical Trial Access
In addition to receiving the best available current therapies for a variety of vestibular disorders, eligible patients with targeted disorders can choose to participate in clinical trials for new treatments that may become tomorrow’s standard of care.